EUVIMEDEUVIMED entdecken
Crossref

Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China

Yizhang Liu, Kun Hu, Yongfang Duan, Xiang Chen, Mi Zhang, Yehong Kuang

Journal of the American Academy of Dermatology · 2025-07 · 93 (1) · 46-54

DOI: 10.1016/j.jaad.2025.02.063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2025-07. Verfasst von Yizhang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnost…. Hauptthemen laut MEDLINE: Psoriasis, Biological Products, Biological Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Natural Science Foundation of China, National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite advances in the availability of effective biologics in psoriasis over the past decade, clinical characteristics, persistence, and safety associated with treatment response have never been systematically investigated. OBJECTIVES: The objective of this study was to evaluate the factors, persistence, and safety associated with super-response (super-responder, SR) or refractory (biologic-refractory patient, BRP) to biologic agents. METHODS: This retrospective analysis included psoriasis patients who initiated their first biologic therapy. Multivariable logistic regression analysis identified predictors for SRs and BRPs. Drug survival used Kaplan-Meier plot analysis. RESULTS: Seven hundred thirty-seven patients were included (140 SRs [19.0%], 34 BRPs [4.6%]). Body mass index

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBiological ProductsBiological TherapyHumansRetrospective StudiesMaleFemaleMiddle AgedChinaAdultTreatment OutcomeSeverity of Illness IndexBody Mass IndexAged

Stichwörter der Autor:innen

biologicbiologic-refractorydrug survivalpsoriasissafetysuper-responder

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China; Furong Laboratory, Cha…

Förderung

  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Liu, Y., Hu, K., Duan, Y., Chen, X., Zhang, M., & Kuang, Y. (2025). Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China. Journal of the American Academy of Dermatology, 93(1), 46-54. https://doi.org/10.1016/j.jaad.2025.02.063

Vancouver

Liu Y, Hu K, Duan Y, Chen X, Zhang M, Kuang Y. Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China. Journal of the American Academy of Dermatology. 2025;93(1):46-54. doi:10.1016/j.jaad.2025.02.063

BibTeX
@article{Liu2025,
  author = {Liu, Yizhang and Hu, Kun and Duan, Yongfang and Chen, Xiang and Zhang, Mi and Kuang, Yehong},
  title = {Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China},
  journal = {Journal of the American Academy of Dermatology},
  year = {2025},
  volume = {93},
  number = {1},
  pages = {46--54},
  doi = {10.1016/j.jaad.2025.02.063}
}
Kostenlos starten →